Process Scale Purification of Antibodies
Regular price
$241.95
Regular price
Sale price
$241.95
Unit price
per
Couldn't load pickup availability
Availability:
In stock
SKU:
9781119126911
Regular price
$241.95
Regular price
Sale price
$241.95
Promoting a continued and much-needed renaissance in biopharmaceutical manufacturing, this book covers the different strategies and assembles top-tier technology experts to address the challenges of antibody purification.
- Updates existing topics and adds new ones that include purification of antibodies produced in novel production systems, novel separation technologies, novel antibody formats and alternative scaffolds, and strategies for ton-scale manufacturing
- Presents new and updated discussions of different purification technologies, focusing on how they can address the capacity crunch in antibody purification
- Emphasizes antibodies and innovative chromatography methods for processing
Publisher: Wiley
Published: 04/03/2017
Pages: 752
Weight: 2.65lbs
Size: 9.30h x 6.40w x 1.50d
ISBN: 9781119126911
About the Author
- Updates existing topics and adds new ones that include purification of antibodies produced in novel production systems, novel separation technologies, novel antibody formats and alternative scaffolds, and strategies for ton-scale manufacturing
- Presents new and updated discussions of different purification technologies, focusing on how they can address the capacity crunch in antibody purification
- Emphasizes antibodies and innovative chromatography methods for processing
Publisher: Wiley
Published: 04/03/2017
Pages: 752
Weight: 2.65lbs
Size: 9.30h x 6.40w x 1.50d
ISBN: 9781119126911
About the Author
Uwe Gottschalk, PhD, is Chief Technology Officer at Lonza Pharma/Biotech, Switzerland. Previously, he served as Group Vice President at Sartorius Stedim Biotech (2004-2014) and in various development and manufacturing capacities at Bayer Health Care (1991-2004). Dr. Gottschalk received a doctorate in chemistry from the University of Münster (Germany) for work on antibody-drug conjugates at the Cancer Research Campaign Laboratories in Nottingham (UK). He is Head Lecturer at the University of Duisburg-Essen, Germany, and has written extensively in the areas of industrial biotechnology and somatic gene therapy.